Release Date: 12/01/22 18:56 Summary: Notice of initial substantial holder for GL1 - Reissued Price Sensitive: No Download Document 520.18KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%